Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: Prev Med. 2019 Mar 29;123:197–203. doi: 10.1016/j.ypmed.2019.03.037

Table 2.

Correlates of Effect Size (Difference in HPV Vaccine Initiation between Minority and White)

HPV VACCINE INITIATION n k Effect Size I2 Difference P
All studies 1,751,281 94 0.0% [-1.8%,1.8%] 98 - -
Correlate
Publication Year 2009–2010 557,222 25 −3.0% [−6.4%,0.3%] 92 ref -
2012–2014 248,137 40 −0.3% [−2.9%,2.4%] 97 2.8% 0.20
2015–2017 945,922 29 2.9% [−0.1%,6.0%] 97 6.0% 0.01
Sampling of Clusters National 1,430,561 60 −0.2% [−2.5%,2.1%] 98 ref -
Regional/Single Site 320,720 34 0.1% [−2.7%,2.9%] 98 0.3% 0.88
Sampling of Individuals Probability 1,369,523 43 1.0% [−1.8%,3.8%] 98 ref -
Convenience 381,758 51 −0.8% [−3.1%, 1.5%] 98 −1.8% 0.34
Sex Female 922,842 80 −1.6% [−3.5%,0.4%] 97 ref -
Male 828,439 26 7.1% [3.9%,10.3%] 99 8.7% <.001
Age Included (years) Under 18 only 1,201,965 35 4.3% [1.7%,6.9%] 98 ref -
Includes 18+ 549,316 65 −2.5% [−4.6%, −0.4%] 97 −6.8% <.001
Source of Race and Ethnicity Data Self-Report 448,820 79 −1.3% [−3.2%,0.6%] 97 ref -
Administrative 1,302,461 15 5.5% [1.5%,9.5%] 99 6.8% 0.003
Source of Vaccination Data Self-report 264,260 64 −3.6% [−5.5%, −1.7%] 95 ref -
Provider-verified 1,487,021 30 6.0% [3.6%,8.5%] 99 9.6% <.001
NIS—Teen Data No 1,604,353 85 −1.1% [−2.9%,0.6%] 98 ref -
Yes 146,928 9 7.9% [3.3%, 12.5%] 98 9.0% <.001

HPV VACCINE FOLLOW-THROUGH
All studies 355,044 41 −9.6% [−12.1%, −7.1%] 96 - -
Correlate
Publication Year 2009–2010 169,326 12 −15.1% [−18.9%, −11.2%] 92 ref -
2012–2014 42,228 12 −6.6% [−10.8%, −2.5%] 90 8.4% 0.004
2015–2017 143,490 17 −6.5% [−10.0%, −3.0%] 90 8.6% 0.001
Sampling of Clusters National 294,758 28 −10.5% [−13.6%, −7.5%] 97 ref -
Regional/Single Site 60,286 13 −7.7% [−12.1%, −3.3%] 93 2.8% 0.30
Sampling of Individuals Probability 291,971 26 −9.7% [−13.0%, −6.5%] 97 ref -
Convenience 63,073 15 −9.4% [−13.5%, −5.4%] 94 0.3% 0.91
Sex Female 259,774 39 −9.4% [−11.9%, −6.8%] 96 ref -
Male 95,270 10 −5.7% [−10.9%, −0.6%] 87 3.6% 0.22
Age Included (years) Under 18 only 163,432 16 −8.0% [−11.8%, −4.2%] 95 ref -
Includes 18+ 191,612 27 −10.9% [−14.0%, −7.7%] 95 −2.9% 0.25
Source of Race and Ethnicity Data Self-Report 71,130 23 −10.0% [−13.4%, −6.5%] 93 ref -
Administrative 283,914 18 −9.2% [−13.0%, −5.5%] 98 0.8% 0.77
Source of Vaccination Data Self-report 7,817 9 −13.7% [−19.3%, −8.1%] 74 ref -
Provider-verified 347,227 32 −8.6% [−11.4%, −5.9%] 97 5.1% 0.11
NIS—Teen Data No 299,188 33 −10.6% [−13.4%, −7.7%] 96 ref -
Yes 55,856 8 −6.3% [−11.5%, −1.2%] 96 4.2% 0.16

Note. Effect size is the difference in HPV vaccine initiation between minority and White. Negative numbers indicate a disparity, minorities had lower HPV vaccination coverage than Whites; positive numbers indicate a reverse disparity. NIS—Teen = National Immunization Survey—Teen.